2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$10.63+$0.10 (+0.95%)
Price as of Jun 23, 2026 5:53 PM EDT- $873.5MMarket Cap
- 138.66%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$10.63+$0.10 (+0.95%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.53 | ||
Change | +$0.49 (+5.15%) | ||
Open | $9.99 | ||
High | $11.01 | ||
Low | $9.89 | ||
Previous Close | $10.00 | ||
Volume | 2,368,325 | ||
30-Day Average Volume | 1,651,516 | ||
1-Week Change | 1.21% | ||
1-Month Change | -26.90% | ||
1-Year Change | 138.66% | ||
3-Year Change | 20.19% | ||
5-Year Change | -61.74% | ||
Fundamentals | |||
Shares Outstanding | 87.3M | ||
Total Assets | $530.6M | ||
Market Cap | $873.5M | ||
Enterprise Value | $823.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.1M | ||
Free Cash Flow | -$46.0M | ||
EBIT | -$53.0M | ||
EBITDA | -$52.9M | ||
Net Working Capital | $466.1M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | 6 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue